ACB
CYNO

Aristotle Capital Boston’s Cynosure, Inc. Class A CYNO Stock Holding History

Aristotle Capital Boston’s Portfolio CYNO Stock Details CYNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-84,899
Closed -$3.87M – 129
2016
Q4 		$3.87M Buy
84,899
+6,033
+8% +$276K 0.53% 88
2016
Q3 		$4.02M Buy
78,866
+3,112
+4% +$162K 0.72% 72
2016
Q2 		$3.69M Buy
75,754
+1,965
+3% +$93.4K 0.72% 71
2016
Q1 		$3.26M Buy
73,789
+6,175
+9% +$242K 0.65% 77
2015
Q4 		$3.02M Buy
67,614
+9,698
+17% +$368K 0.62% 80
2015
Q3 		$1.74M Buy
57,916
+1,227
+2% +$44.1K 0.42% 92
2015
Q2 		$2.19M Buy
56,689
+15,762
+39% +$554K 0.5% 88
2015
Q1 		$1.25M Buy
40,927
+14,985
+58% +$452K 0.39% 92
2014
Q4 		$711K Buy
+25,942
New +$659K 0.36% 95

Other funds holding CYNO

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Aristotle Capital Boston's CYNO Position: Q1 2017 in Review

Aristotle Capital Boston sold out of Cynosure, Inc. Class A (CYNO) in Q1 2017, closing a stake of 84,899 shares — an estimated $3.87M sold.

Aristotle Capital Boston first reported a position in CYNO in Q4 2014 and held it in 9 quarters. The position peaked at $4.02M in Q3 2016. 3 funds tracked by Wall St. Rank hold CYNO as of Q1 2017.

  • Aristotle Capital Boston reported no remaining Cynosure, Inc. Class A position as of Q1 2017 after selling out during the quarter.
  • Aristotle Capital Boston sold 84,899 Cynosure, Inc. Class A shares in Q1 2017, an estimated $3.87M.
  • Aristotle Capital Boston first reported a position in Cynosure, Inc. Class A in Q4 2014 and held it in 9 quarters.
  • Aristotle Capital Boston's Cynosure, Inc. Class A position peaked at $4.02M in Q3 2016.
  • 3 funds tracked by Wall St. Rank held Cynosure, Inc. Class A as of Q1 2017.

Based on Aristotle Capital Boston's 13F filing for Q1 2017, filed 12 May 2017.